Mary Tyler Moore Vision Initiative Welcomes Regeneron and Adaptive Sensory Technology
Regeneron Pharmaceuticals, Inc. and Adaptive Sensory Technology have joined the MTM Vision Consortium as founding and device members. Their participation will help scale the MTM Vision Biorepository and Resource Center and the MTM Vision Endpoints and Biomarker Data Resource Center, supporting expanded human ocular sample collection and characterization, enhanced biological and clinical data analysis, validation of useful biomarkers and endpoints supporting new regulatory pathways, and sample and data sharing.
Primary source
Company press release (PR Newswire), November 5, 2026
Mary Tyler Moore Vision Initiative Welcomes Regeneron and Adaptive Sensory Technology to Its Consortium
Read the source: Mary Tyler Moore Vision Initiative Welcomes Regeneron and Adaptive Sensory Technology to Its Consortium prnewswire.com
Machine-summarized from the source above; not independently reported. How we use automation